Xin Zhai

Title: Innovations of Inventor Xin Zhai

Introduction

Xin Zhai is a notable inventor based in Shenyang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target c-Met kinase, which is associated with various diseases, including cancer. With a total of two patents to his name, Zhai's work is paving the way for new therapeutic options.

Latest Patents

Xin Zhai's latest patents include "Quinoline derivatives and their applications" and "Quinoline and cinnoline derivatives and their applications." The first patent relates to a series of quinoline derivatives that exhibit potent inhibitory activity against c-Met kinase. These compounds, along with their pharmaceutically acceptable salts and hydrates, are intended for the preparation of medicaments aimed at treating and preventing diseases caused by abnormal expression of c-Met kinase, particularly cancer. The second patent similarly focuses on quinoline and cinnoline derivatives, emphasizing their potential in the same therapeutic applications.

Career Highlights

Zhai has worked at Shenyang Pharmaceutical University and Shenyang Pharmaceutical University (Benxi) Pharmaceutical Science and Technology Co., Ltd. His academic and professional experiences have significantly influenced his research and innovations in the pharmaceutical field.

Collaborations

Some of his notable coworkers include Ping Gong and Yanfang Zhao, who have contributed to his research endeavors and collaborative projects.

Conclusion

Xin Zhai's innovative work in developing quinoline and cinnoline derivatives showcases his commitment to advancing medical science. His contributions are expected to have a lasting impact on the treatment of diseases related to c-Met kinase.